Role of diabetes in atherosclerotic pathogenesis. What have we learned from animal models?

Diabetes & Metabolism
C Renard, E Van Obberghen

Abstract

Diabetes mellitus is associated with a greater risk of developing atherosclerosis and its complications: stroke, myocardial infarction, and peripheral vascular disease. In patients with diabetes, atherosclerosis represents a complex multifactorial disease with increased lesion progression and severity compared to the nondiabetic population. Several risk factors have been proposed to explain the increased risk of cardiovascular disease with diabetes. They include: hyperglycaemia, dyslipidemia, accelerated formation of advanced glycation end-products (AGEs), increased oxidative stress, and genetic factors. It is difficult to precisely establish the elements leading to diabetes-accelerated atherosclerosis by means of epidemiological studies because all these factors coexist in diabetic patients. Thus, diabetic animal models that reproduce exacerbation of atherosclerosis would be helpful to understand why atherosclerosis is accelerated by diabetes, and to design appropriate treatments to limit its progression. This review analyzes most of the animal models developed to reproduce diabetes-accelerated atherosclerosis, and summarizes the effects of hyperglycaemia and lipid abnormalities on atherogenesis.

References

May 1, 1976·The Tohoku Journal of Experimental Medicine·Y GotoN Masaki
Jun 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·E L Bierman
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W PalinskiJ L Witztum
Jul 1, 1988·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·B G NordestgaardK Kjeldsen
May 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·K J Williams, I Tabas
May 1, 1994·Metabolism: Clinical and Experimental·P M NishinaB Paigen
May 1, 1994·The Journal of Clinical Investigation·S IshibashiD K Burns
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·Y NakashimaR Ross
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Apr 1, 1996·The Journal of Clinical Investigation·V V KunjathoorR C LeBoeuf
Oct 31, 1998·Nature·J M Friedman, J L Halaas
Oct 16, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·S A HuberR Tracy
Dec 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·J L DixonM Sturek
Dec 8, 2000·Biochimica Et Biophysica Acta·A M SchmidtD M Stern
Dec 8, 2000·Experimental Animals·J YamanouchiY Yoshikawa
Mar 10, 2001·Cell·C K Glass, J L Witztum
Jun 26, 2001·Diabetes·R G GerrityT Kimsey
Nov 21, 2001·The Journal of Clinical Investigation·S KonstantinidesD J Loskutoff
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Peter F BodaryDaniel T Eitzman
Jun 18, 2002·Journal of Cellular and Molecular Medicine·L NiculescuM Simionescu

❮ Previous
Next ❯

Citations

Jun 11, 2011·The Journal of Biological Chemistry·Te-Chuan ChenCheng-Nan Chen
May 2, 2012·The Journal of Clinical Investigation·Kai Soo TanYunn-Hwen Gan
Feb 5, 2013·Cardiovascular Diabetology·Vedat TiyeriliCornelius F H Mueller
Apr 9, 2008·Journal of Leukocyte Biology·Kazuhiro OmoriThomas E Van Dyke
Nov 26, 2011·Canadian Journal of Physiology and Pharmacology·Glaucy Rodrigues de AraujoDaniela Caldeira Costa
Aug 28, 2007·Biochemical and Biophysical Research Communications·Hong ZhaoZhongQiu Xin
Jul 29, 2006·The Journal of Pharmacy and Pharmacology·Barbara Gawronska-SzklarzMarek Drozdzik
May 23, 2014·Diabetes/metabolism Research and Reviews·Randhir SinghRakesh Gollen
Apr 23, 2015·Asian Pacific Journal of Tropical Medicine·Hyun Ah JungJae Sue Choi
Oct 24, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael Mendoza, Zobair Younossi
Mar 26, 2009·BioFactors·Mira Rosenblat, Michael Aviram
Jun 5, 2008·American Journal of Physiology. Endocrinology and Metabolism·Andreas PeterErwin Schleicher
Oct 24, 2009·Molecular and Cellular Biochemistry·F L ChenR M Hu
Jan 14, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Li-Min LiKe Zen
Jun 14, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Yongbi YangGuiping Ren

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.